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1. Introduction 
Modern intensive therapy is armed with very sophisticated methods, however sepsis is still 
one of the most challenging issues of medicine. Death rate in patients caused by sepsis 
remains high and reaches about 30-80% (Yegenaga I. et al., 2004). This problem is especially 
important in oncology, as every sixth septic patient has a diagnosis of cancer; and the death 
risk of such patients is 30% higher (Angus D.C. et al., 2001). 
The established bacteriologic paradigm of sepsis implies an infectious component for its 
development. The priority in the pathogenesis of this disease has been assigned to 
microorganisms, and therefore sepsis is regarded primarily as an infective disease. 
However, over the last decades there have appeared tendencies for an essential revision in 
the understanding of mechanisms of sepsis development; inflammatory reactions of the 
organism are now regarded as important as infection. In particular, according to a current 
definition, approved by American College of Chest Physicians/Society of Critical Care 
Medicine (ACCP/SCCM) Consensus Conference, “sepsis is a systemic inflammatory 
response syndrome developing in response to an invasion of different pathogenic 
microorganisms, which is diagnosed if an infective agent and two or more signs of the 
systemic inflammatory response are present” (USA, Chicago, 1991).  
Systemic inflammatory response syndrome (SIRS) includes the whole set of the clinical 
manifestations of systemic inflammatory response (SIR), which is a generalized form of 
inflammatory reaction and is formed as a result of an excessive immune cell activation that 
produce different types of mediators (cytokines, leukotrienes, thromboxanes, etc.). SIRS is a 
necessary component of sepsis, however, it is not the same, as SIRS may be induced by 
different non-infective causes such as trauma, pancreatitis, etc. Thus, signs of systemic 
infection are necessary to prove diagnosed sepsis. Besides, it should be taken into account 
that bacteremia is not pathognomonic to sepsis.  The rate of diagnosed  bacteremia even in 
the most serious cases does not exceed 45% if accurate  techniques of blood sampling and 
modern microbiologic methods are applied. Detection of microorganisms in the patient’s 
peripheral blood with no clinical and laboratory test conclusion of SIRS may be considered 
as transitory bacteremia that is not necessarily caused by septic process. Some authors 
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recommend differentiating localized focus of infection from true sepsis even if it is 
associated with the symptoms of systemic inflammatory reaction. In about half of cases (30-
60%) when clinical symptoms of sepsis were evident, it was impossible to isolate live 
microorganisms from the blood or find the focus of infection.  
 
Fig. 1. Triggering factors and mediators of sepsis. 
The disease status that demonstrates the whole set of septic symptoms but lack of infection 
is regarded like pseudosepsis or sepsis-like syndrome. Trigger factors initiating systemic 
inflammatory response might be derivatives of microorganisms (exo- or endotoxins) rather 
than microorganisms themselves, or even factors of non-infective origin including 
endogeneous factors (such as tissue factors, elastin, thrombin, etc.), which appear primarily 
during organ or tissue damage (Fig. 1) as a result of traumas, burns, etc.    
Clinical symptoms of sepsis as well as organ or multi-organ dysfunction syndrome (MODS) 
may develop in response to endo- and exotoxins of microorganisms in the absence of 
bacteremia (septicemia) or localized focus of infection. The macroorganism reaction to 
bacterial products displays totally the whole symptom complex that is characteristic for 
bacterial sepsis.  LPS poisoning does not only induce clinical presentations of sepsis and 
septic (endotoxic shock), but leads to pathomorphologic changes characteristic for septic 
conditions (Angus D.C. et al., 2001).  
Present understanding of sepsis states that it is a systemic inflammatory response of the 
macroorganism, which develops as a result of interaction of the immune system with 
bacteria or their toxins and is mediated by the over-expression of a complex of humoral 
factors: cytokines and other substances (platelet activation factor, metabolites of arachidonic 
acid, endotelin-1, and complement components).    Local tissue damage during SIRS arises 
from the release of active oxygen forms, proteases and escalation of cytokine synthesis.  
Such vision of sepsis pathogenesis suggests that new diagnostic and prognostic markers of 
this condition should be identified in patient’s immunologic parameters. Following this 
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concept, new therapeutic strategies of inactivation or elimination of SIR triggers and 
mediators are being developed.  
2. Bacterial toxins: triggers of inflammation  
Infective agents have various factors of virulence which can affect protective reactions of the 
body. In septic and inflammatory conditions cascade of events initiated by microbes and 
their products may develop out of control. Immune effectors recognize  pathogens, firstly, 
by innate immunity receptors detecting different pathogen-associated molecular patterns 
that  include various components of microbial cell wall (such as, LPS –lipopolysaccharide, 
peptidoglycan, lipoteichoic acid, mannan, flagellin, bacterial DNA, viral double-helical 
RNA, glucan and intracellular components, etc.)   
Bacterial toxins, primarily LPS of gram-negative bacteria, have significant impact on 
activating mechanisms of inflammation and may induce or potentiate systemic 
inflammatory response in the absence of microbial cells. In particular, it was shown that in 
humans LPS in the minimal dose (4 ng/kg) initiates release of inflammatory mediators, 
alterations of hemostasis and fall of the blood pressure resulting from the decrease of the 
cardiac output and vascular resistance. Sepsis-like conditions were described in volunteers 
after injections of high endotoxin doses as well as in patients receiving therapies based on 
LPS-immunomodulators (Laurenzi L. et al., 2004, Zucker T. et al., 2004). Sepsis-like 
syndrome is observed in patients after cardiac surgery, closed injury, and in patients 
resuscitated after cardiac arrest. 
One of the  major mechanisms of infection is penetration of normal microflora and 
substances including endotoxins into blood circulation from the natural organism 
biocoenoses, mainly from the bowels (Annane D. et al., 2005). Translocation of bacteria and 
their toxins into the bloodstream might be caused by changes in the mucous intestine tunic 
(Moore F.A. , 1999). Nevertheless, impairment of the intestine permeability most often has a 
secondary origin and results from the SIR to trauma, surgical stress, burn, high-dose 
antibiotic therapy and other damaging factors (Deitch E.A.&Bridges R.M. , 1987, Balzan S.et 
al., 2007). In cancer patients, risk of bacterial toxin translocation increases due to disorders of 
the intestine mucous barrier function caused by the major disease and especially, by anti-
tumor aggressive therapy. An additional unfavorable factor is older age of patients because 
of the age-related changes in the intestines permeability. These patients, despite of the 
widely accepted view about immunity involution and down-regulation of immune reactions 
in the elderly, demonstrate an enhanced response to bacterial toxins. For example, patients 
over 65 have a more significant drop of the blood pressure after injections of minimal LPS 
doses (2 ng/kg) compared with younger individuals. The phenomenon is apparently linked 
to the systemic chronic inflammatory reaction of the elderly, associated with a higher initial 
level of pro-inflammatory factors.  
When LPS enters blood circulation, it partly links to the  LPS-binding protein (LBP) and the 
newly formed complex interacts with CD14-positive cells, such as macrophages.   LPB 
potentiates LPS transport to receptors of macrophages (CD14) and stimulates functional 
activity of these innate immunity effectors (Takeshita S. et al., 2002). The endotoxin-shipping 
function in the blood also refers to the soluble circulating macrophage CD14-receptors. A 
number of studies showed an increase in these markers in patients with sepsis, including 
cancer patients (Myc A. et al., 1997, Nijhuis C. S. et al., 2003).  
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Our data show that LPS serum concentration increases in patients with sepsis aggravated by 
organ failure or MODS.  Particularly, in contrast to healthy volunteers, whose blood almost 
lacks LPS, patients with kidney or hepatic failure with no symptoms of SIRS showed 
moderate increase of LPS serum concentrations (0,1-0,2 IU/ml), while patients with sepsis 
and septic shock had markedly increased blood serum concentrations of this bacterial toxin 
– median parameter in the group was 0,55 IU/ml, sometimes reaching 6,25 IU/ml (Fig. 2).  
 
Fig. 2. Comparative analysis of LPS serum level in groups of survival and died patients with 
sepsis and in healthy volunteers.  
A high LPS concentration in peripheral blood is generally associated with a drop of LPB 
level. In patients with sepsis the ratio of blood serum concentrations LPS/LPB is on average 
ten-fold higher than in healthy individuals. Therefore, dynamic growth of LPS concentration 
and decrease of LPB level in sepsis may be considered as negative prognostic factors.  
3. Cytokines  
Over the last years, a lot of data have been accumulated that discuss the role of endogenic 
bioregulators of different origin (cytokines, kinins, phospholipids, arachidonic acid 
metabolites, etc.) in development of structural and functional alterations leading to systemic 
inflammatory reactions and sepsis. Immune mediators – cytokines have an absolutely 
important role in inflammation pathogenesis. Their high biologic activity and a small 
difference between effective and toxic concentrations make them key factors both in natural 
physiologic processes and pathologic conditions. As it was mentioned earlier, a triggering 
mechanism of SIRS, besides bacteria and/or their toxins, might be a trauma, including 
surgical intervention. With no microbial components it may also initiate an inflammatory 
cascade, leading to cellular damage and organ dysfunctions. Different endogenous factors, 
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so-called alarmins, which are activated by tissue damage (for example, necrotic cells, RNA, 
urine acid crystals, etc.), may bind leucocyte receptors and induce systemic inflammatory 
response or “sepsis with no infective agent”. A term “alarmin” was suggested by J. 
Oppenheim for endogenous stress molecules that provide signals about tissue and cell 
damage (Oppenheim J.J.& Yang D., 2005).  
Thus, excessive concentrations of these endogenous modulators provoke development of 
pathophysiologic abnormalities leading to organ failure or MODS. However, despite 
numerous studies looking at prognostic or diagnostic significance of cytokine concentrations 
in the serum of patients with purulent and septic complications, there is still disagreement 
on the topic. Serum cytokine low levels are registered in the peripheral blood of many 
patients regardless clinical symptoms of sepsis or septic shock.  At the same time, some 
authors report data of increased concentrations of several cytokines such as  interleukin(IL)-
8, tumor necrosis factor (TNF)ǂ, IL-6 in the peripheral blood of patients with sepsis 
(Calandra T.et al., 1990,  Anderson R.&Schmidt R., 2010, Gaïni S. et al., 2006).  
Risk of SIRS development is extremely high in cancer patients, as the necessary extensive 
surgery stimulates release of pro-inflammatory cytokines that may promote development of 
systemic inflammatory response (Hildebrand F. et al., 2005, Lenz A. et al., 2007). Some 
authors suggested diagnostic and prognostic significance of TNF serum level (Calandra T., 
1990). The results showed both increased as well as similar to the control group 
concentrations of TNF in serum of patients with severe sepsis. An unfavorable course of 
the septic process was observed in the cases of low basic TNF level or its negative 
dynamics (TNF level dropped from 30,4  2,7 pg/ml to 15,8  6,3 pg/ml). Originally high 
TNF in the blood of septic patients (1020,7  30,1 pg/ml) was considered as a “cytokine 
cascade out of control”. They also presented data demonstrating that intensive therapy in 
the group of patients with originally high TNF concentration leaded to its significant 
decrease (from 680,4  32,7 pg/ml to 450  16,7 pg/ml), which was associated with 
favorable prognosis. TNF level varied in a wide range from 50 to 3500 pg/ml in patients 
with septic shock. Median TNF level was 180 pg/ml in the group of survived patients; and 
330 pg/ml in the group of the deceased.  On the basis of these data, contradictory 
conclusions were made about prognostic significance of pro-inflammatory cytokine serum 
levels in general and TNF, in particular. However, many researchers agree that both high 
and low TNF serum levels in critical conditions may be regarded as a poor prognostic 
parameter (Martin C.et al., 1994, Quinn J.V.&Slotman G.J., 1999). 
According to our data, only the concentration of IL-6 was significantly increased in the 
peripheral blood of cancer patients with sepsis (Table 1). The highest mediator levels were 
observed in patients with septic shock. A probable cause of the pro-inflammatory cytokine 
increase in the patients’ blood could be its overproduction by the resident macrophages, in 
particular, by the hepatic Kupffer cells. Besides TNF, IL-6 is one of the probable markers of 
severity of an infective or non-infective stress.  It induces production of a wide range of 
proteins of the acute phase that regulate inflammation process. In septic shock, the cytokine 
may directly affect organs and tissues; in particular, it may suppress myocardium. Various 
studies investigated the role of this cytokine in pathogenesis of septic shock, MODS and 
other systemic processes and its prognostic significance; however, their conclusions are 
somewhat contradictory (Anderson R.&Schmidt R., 2010, Pinsky M.R., 2004). 
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Groups IL-6 IL-8 IL-10 INFǄ TNFǂ TNF ǃ IL-1ǃ IL-4 IL-17 
Cancer 
patients with 
sepsis 
203* 17 48 0 4 4 1 6 31 
61÷494 6÷130 31÷163 0÷16 0÷30 4÷26 0÷28 3÷13 0÷73 
healthy 
volunteers 
0 3 80 2 0 0 0 10 9 
0÷1 0÷11 0÷108 0÷16 0÷0 0÷9 0÷0 2÷12 6÷19 
* − significant difference compared to the control group of healthy volunteers (P<0.01) 
Table 1. Cytokine profile of cancer patients with sepsis compared to healthy volunteers 
(median, 25th ÷75th  quartiles), pg/ml. 
On the whole, the above data suggest that determination of free cytokine serum 
concentrations in the peripheral blood of patients with septic complications presents little 
information, except for IL-6, which is statistically significantly increased in patients with 
sepsis, and, especially, with septic shock.  Therefore IL-6 is the only serum cytokine, which 
concentration might be recommended as a marker for sepsis. A possible reason of low 
importance of the cytokine profile determination in sepsis may be due to the fact that 
commercially available kits are designed to evaluate concentrations of free (soluble) 
cytokines only. It is a serious obstacle for the estimation of the total cytokine concentrations 
secreted into the blood circulation. Even if free cytokines are not detected in the blood, their 
receptor-bound complexes may be circulating. As a result, “hidden cytokinemia” – high 
cytokine concentrations non-detectable by conventional methods – may take place. 
Therefore, low levels of serum cytokines do not necessarily reflect the true mediator 
concentrations in blood serum and may result not only from insufficient activity of immune 
effectors of cancer patients, but also from specific binding with increased concentrations of 
cytokine soluble receptors. A number of studies reported on the statistically significant 
increase of concentrations of soluble cytokine receptors: TNF receptors (sTNF-R I and sTNF-
R II) (Zhang B.et al., 1998), IL-1 − sIL-1 RII (Müller B., 2002) and decrease of soluble IL-6 
receptor (sIL-6 R) (Frieling J.T.M.et al., 1995, Zeni F. et al., 1995) in patients with sepsis. 
However, other researchers presented different results (Barber M.D.et al, 1999). 
The data of our studies showed that only sTNF-RI (Ȟ55) serum level was significantly more 
enhanced in cancer patients with sepsis compared with control group of healthy volunteers.  
However, the comparative analysis of cytokine and their soluble receptor concentrations in 
the blood of survived and deceased patients with sepsis showed that simultaneous increase 
of IL-6, IL-8, IL-10, sTNF-RI,  sIL-1RII and sIL-6R was associated with poor prognosis. 
Probably, the mentioned facts result from the so-called “cytokine storm” and reflect the 
extreme imbalance of the immune system in sepsis leading to the fatal outcome. This 
suggestion is supported by the increased level of both pro-inflammatory cytokines (IL-6, IL-
8) and anti-inflammatory IL-10 in the patients died from sepsis  
Comparative studies of immunocompetent cell potential for cytokine secreting presented 
more precise data. The level of spontaneous production of these endogenous bioregulators 
characterizes the original physiologic activity of the blood cells. The intensity of the 
stimulated cytokine production helps to determine the potential reactivity in response to a 
possible infection.   
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The obtained data from our studies showed that blood cells of septic cancer patients with 
spontaneous overproduction of certain cytokines (IL-6, IL-8) are mostly non-responsive to 
any stimulation. The observation suggests that immune effectors in this group of patients 
are over-stimulated.  
The inflammatory reaction in response to trauma or infection is induced mainly by innate 
immunity and develops rapidly at the early stage. Endogenous inflammation mediators 
synthesized by immune cells in response to microbial components or tissue factors are 
released within few minutes and may peak within 1-3 hours in peripheral blood. These 
factors play a major role in the formation of the protective response to infection (they 
enhance bactericidal activity of phagocytes, promote recruitment of leukocytes to the 
infection site, stimulate hemopoiesis, and cause fever). However, inflammatory over- 
reaction leads to an excessive release of inflammatory mediators both of peptide (cytokines) 
and lipid nature (metabolites of membrane lipids –leukotrienes, thromboxanes, platelet 
activation factor). These substances, besides protective functions, are highly toxic and may 
cause hemodynamic imbalance, metabolic and pathologic alterations that are characteristic 
for sepsis and septic shock. Activation of anti-inflammatory factors, as well as of inhibitors 
of inflammatory mediators (prostaglandin E2, IL-1Ra, IL-10 and TGF-ǃ), takes place during 
SIRS and is considered as compensatory anti-inflammatory syndrome, a protective response 
limiting tissue damage by endogenous pro-inflammatory factors. On the other hand, 
prevalence of anti-inflammatory mediators may lead to immune suppression and anergy of 
immune cells (Keel M.&Trentz O., 2005). Evidently, both hyper- and hypo-inflammatory 
phases may follow each other or develop independently from each other, according to the 
original reactivity of the organism. Both conditions of hyper- and hyporeactivity are equally 
dangerous and may cause fatal outcome.  
4. Functional activity of leukocytes  
So far a lot of data have been collected to characterize immune status of cancer patients with 
suppurative septic complications (Martin C., 1994, Quinn J.V.&Slotman G.J., 1999, Anderson 
R.&Schmidt R., 2010, Pinsky M.R. et al., 2004, Zhang B. et al, 1998, Frieling J.T.M.et al., 1995). 
Although most of the studies look at parameters of humoral immunity, particularly, at 
assessment of cytokine profile, a higher interest has been seen in studying functions of 
immune competent cells over the last years. Special attention is aimed at effectors of innate 
immunity (natural killers, granulocytes and monocytes), which play a key role in 
pathogenesis of sepsis (Zeerleder S., 2005). A number of authors show an increasing 
suppression of cellular immunity with septic background that reveals as decreased function 
of immune competent cells due to high rate of immunosuppressive agents (IL-10) and 
decrease of regulatory peptides (IL-12). On the other hand, there are data that prove 
enhanced production of pro-inflammatory cytokines (IL-8, TNFǂ, IL-6, IL-1ǃ) in cancer 
patients, which level is many times higher than that in healthy individuals (Rigato O.et 
al., 1996, Kumar A.T. et al., 2009). The logic consequence of this phenomenon may be higher 
cellular functioning, mostly - innate immunity effector cells function. In the environment of 
bacteriemia and bacterial toxicity these cells are responsible for natural resistance to 
infectious agents. However their super activation triggers cascade hyperproduction of 
inflammatory mediators which initiate  SIRS (Angus D.C. et al., 2001, Hildebrand F. et al., 
2005). 
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The results of our studies showed that cancer patients with sepsis have a significant increase 
of natural killer (NK) cells activity as compared with cancer patients having no sepsis or 
healthy volunteers. These data comply with results of other authors who demonstrated an 
enhanced function of NK in patients with sepsis (Giamarellos-Bourboulis E.J.et al., 2006, 
Yoneda O. et al., 2000). The observed phenomenon seemed to be associated with the 
enhanced rate of IL-12 in blood serum of patients with severe sepsis or septic shock due to 
the fact that IL-12 stimulates NK and T-killer cells cytotoxicity as a result of secreting 
molecules  involved in cytolytic reactions (gransymes A and B) (Zeerleder S., et al. 2005). 
Neutrophils are the first line of protection against acute infections and play an important 
role in pathogenesis of sepsis (Segal A.W. , 2005). On the one hand they are major players in 
eliminating infectious microorganisms, on the other hand – an excessive release of oxidants 
and proteases by neutrophils leads to damaging organs and tissues. Neutrophils are 
involved both in inflammatory processes and natural immunity effects migrating to the site 
of infection or inflammation to eliminate infectious agents. Besides that they produce signals 
about invasion of a foreign agent to alert effectors of innate immunity. These signals induce 
activation of other cells, such as, monocytes/ macrophages as well as epithelial and mast 
cells and trombocytes.  On activation neutrophils generate various chemotaxiȟ factors 
attracting macrophages. Because of their common origin neutrophils and macrophages have 
common functions (phagocytosis, similar behavioral kinetics in infectious and inflammatory 
process, anti-microbial and immunomodulating functions). Activated neutrophils releasing 
chemokines stimulate and recruit to the inflammation site monocytes and macrophages and 
may  effect on macrophage differentiation into pro- or anti-inflammatory subtype (type I or 
type II macrophages).   In addition to release of pro-inflammatory cytokines neutrophils also 
secrete reactive oxygen radicals that induce acute tissue destruction, such as lung 
destruction in acute reactive distress syndrome  (ARDS) or pneumonia (Kumar V. et al., 
2010). Besides phagocytosis and secretion of anti-bacterial molecules neutrophils form so-
called extra-cellular traps. Extra-cellular traps are formed from the decondensated 
chromatin and the contents of some granule, as well as from the cytoplasmic proteins and 
can interact both with gram-negative and gram-positive bacteria leading to destruction of 
virulent factors and killing bacteria. However the excessive reaction of innate immunity 
following bacterial infection may lead to immune suppression in the end. Part of this 
condition is impairment of neutrophil phagocytic activity, which is the major component 
determining the status of anti-infectious defense (Kumar V. et al., 2010, Giamarellos-
Bourboulis E.J. et al., 2010, Volk H.D. et al., 1999).  
Patients with sepsis and the background of neutrophil sequestration can often develop 
complications in tissues, such as ARDS, and excessive activation of neutrophils is associated 
with lung destruction (Kumar V. et al., 2010, Giamarellos-Bourboulis E.J. et al., 2010).  
There is a number of data that demonstrate long-term cellular over-production of pro-
inflammatory cytokines  (IL-8, TNFǂ, IL-6, IL-1ǃ) in cancer patients with sepsis, which  can 
effect neutrophil functions (Martin C. et al.,  1994, Zhang B. et al., 1998, Frieling J.T.M. et al., 
1995, Barber M.D. et al., 1999, Rigato O. et al.,  1996, Segal A.W., 2005). The results revealed 
that in most cases the phagocytotic activity of neutrophils of cancer patients with sepsis  
(phagocytic index and phagocytic number) were higher than those of healthy volunteers (in 
2,6 and 6,3 times, respectively) (Fig. 3a,b, Fig.4 a,b). This phenomenon may be the results of 
increased production of pro-inflammatory cytokines, in particular IL-8: key cytokine 
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involved in recruitment of neutrophiles into the inflammation site and stimulating their 
function (Hammond M.E. et al., 1995). 
  
  a Phagocytic index          b Phagocytic number 
*− values  that have reliable difference from those of healthy volunteers   (p<0,05). 
Fig. 3. Parameters of phagocytosis rate of blood granulocytes in cancer patients with sepsis 
and patients with no septic symptoms in comparison with healthy volunteers (median, 
25%÷75%).  
 
   
            a      b 
Fig. 4. Microphotos of neutrophils in peripheral blood of healthy volunteers (а) and cancer 
patient with sepsis (b ) after incubation with latex particles (t=40 min). 
Patients with sepsis have a significant increase in activation of oxygen dependent 
mechanisms of phagocytes as compared to those of patients with no complications or 
healthy volunteers (5-fold and 15-fold, respectively) that points to a high rate of activation of 
intracellular bactericidal systems when there is septic process (Fig. 5).  
Hydrogen peroxide combined with myeloperoxidase (enzyme of primary neutrophil 
granules) and halogen ions forms an effective bactericidal system that kills bacteria by 
halogenation of the cellular wall (Zychlinsky A. et al., 2003). But phagocytes release these 
endogenous active substances into the inter-cellular medium so that they also destroy self-
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tissues and thus they become involved in developing organ dysfunction or MODS (Thomas 
S. et al., 2004). 
Previous studies suggest that the basis for MODS in critical conditions is the impairment of 
vessel endothelium, which was the result of active function of immune competent cells 
induced by microbial products. Therefore super-activation of effectors of innate immunity 
(neutrophils, natural killers) may be considered as an important link in pathogenesis of 
organ or multi-organ dysfunction syndrome. 
Excessive reaction of innate immune system after contact with bacterial infection can lead to 
immune suppression. A part of this condition is the disorder in phagocytic function of 
neutrophils, which to a high extent determines   anti-infectious defense (Volk H.D. et al., 
1999, Alves-Filho J.C. et al., 2010, Giamarellos-Bourboulis EJ et al., 2010).  
One of the results of the developing immune suppression in patients with sepsis can be 
decreased number of lymphocytes that is associated with their sequestration in the 
inflammation site or their apoptotic death as a result of the excessive production of pro-
apoptotic factors. Clinical studies showed  marked T-cell lymphopenia with its maximum 
within a few days. Absolute and relative number of CD4+ and CD8+ T-lymphocytes 
reduces. At the same time percentage of B-lymphocytes in the peripheral blood goes up 
(Murphy R.&DeCoursey T. E., 2006, Holub M. et al., 2000). Essential alterations were 
observed in NK examination (Emoto M. et al., 2002, Kerr A.R., et al.,  2005). 
 
*− values  that have reliable difference from control (p<0,05); 
**− results of the induced NB-test  reliably different from the results of spontaneous  NB-test  (p<0,05). 
Fig. 5. Rate of metabolic activity of neutrophils in peripheral blood of cancer patients in 
comparison with those of healthy volunteers in spontaneous and induced  NB-test (nitrone 
blue test) (median, 25%÷75%). 
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Peripheral blood NK number enhances at the early stage of sepsis in patients with sepsis 
(Giamarellos-Bourboulis E.J. et al., 2006), while in patients with septic shock their relative 
number decreases (Holub M. et al., 2000).  
5. Apoptosis of the immune cells after trauma  
Apoptosis of various immune cells is an important part of immune suppression 
development in response to an emergency situation (trauma, burns, infection). Suppression 
of active immunity due to the death of monocytes,  macrophages and lymphocytes can 
enhance risk of opportunistic infections. Moreover, a higher rate of apoptosis in lymphoid 
tissues and parenchyma organs may lead to disorders in cellular homeostasis and the 
following inadequate response of the organism as a whole including development of 
MODS.  
Clinical and experimental studies of trauma and burns showed that enhanced production of 
endogenous mediators of inflammation (heat shock proteins, free oxygen radicals, NO, TNF, 
IL-1 and IL-6) could activate signaling pathways of apoptosis in different immune cells. 
Increased expression of apoptotic markers  on T-cells (Fas и FasL) was observed in patients 
who underwent surgery that makes reason for   lymphopenia leading to a higher risk of 
post-surgical infections. However, some authors reported about decrease of apoptotic 
marker on leukocytes in sepsis and SIRS  (Härter L. et al., 2003, Sayeed M.M., 2004, 
Papathanassoglou E.D.E. et al., 2005, Jimenez M.F., et al. 1997, Lee WL & Downey GP. , 
2001). The expression level of this marker on neutrophils correlates with the severity of the 
inflammation (Fialkow L. et al., 2006). Apparently, alterations in apoptosis regulation as the 
process responsible for the elimination of fading cells play an essential role in pathogenesis 
of sepsis and multi-organ dysfunction syndrome (Pierozan P. et al.,2006, Mahidhara R. et al, 
2000).  
6. Platelets in sepsis 
Platelets may be considered as a linking chain between innate immunity and homeostasis. 
Activated platelets can form clusters in blood circulation system that leads to thromboses 
and their sequestration in microcirculation often leads to dessiminated inter-vessel blood 
coagulation.   
Systemic capillary thrombosis in situation of inter-vessel blood coagulation is one of the 
reasons for multi-organ dysfunction. Moreover, extended and long-term activation of the 
coagulation system results in exhausted factors of coagulation and platelet function, which 
causes increased bleeding.  
7. Immunoglobulins 
Imbalance of humoral immunity that develops in sepsis presents quantitative and 
qualitative changes in serum immunoglobulins. A lot of authors report about reduction of 
immunoglobulins A, G, М and their subtype levels in SIRS (Kyles B.D.M.& Baltimore J., 
2005, Tabata N. et al., 1995). The results of a prospective study (Dietz S. et al., 2010) of 543 
patients with sepsis demonstrated that half of them had physiological normal IgG level in 
peripheral blood (6,1-11,9 g/dL). However intra-venous infusion of immunoglobulins in 
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patients with systemic inflammatory processes is widely used (Berlot G. et al, 2007, Jenson 
H.B., 1998, Pildal J.& Gotzsche P.C., 2008). On the other hand, some authors state that there 
was no reliable increase of survival in patients with sepsis after treatment with exogenous 
immunoglobulins (Alejandria M.M. et al., 2002, Werdan K., 1999). 
8. Immunological imbalance in patients with sepsis 
At present there is a standpoint of the massive inflammatory reaction as a result of systemic 
release of cytokines that is the basic cause for  MODS (Goris J.A. et al., 1985). A MODS is the 
result of endothelial cell damage, impairment of vessel penetrative capacity, micro circular 
disorders with developing cellular hypoxia and finally, cell apoptosis with the release of 
immune or necrotic proteins.  Kidneys and gastro-intestinal tract are highly sensitive to 
micro-circular disorders, which lead to necrosis of renal tubules that enhances  
concentration of serum creatinine, develops oliguria or anuria and necrosis of intestine 
fringes. Excessive inflammatory reaction may change to areactivity that leads to immune 
suppression (and even to immunological paralysis) and joining secondary infection. 
Pathological morphological analysis often cannot detect correspondence between 
histological results and the grade of organ dysfunction registered in patients who died from 
sepsis. The number of dead tissue cells of heart, kidneys, liver and lungs can be insignificant 
to reflect the marked organ dysfunctions. Apparently, most symptoms of organ 
dysfunctions in patients with sepsis can be due to "cell hibernation" or "cell stunning” in the 
way it happens in myocardial ischemia  (Sawyer DB & Loscalzo J., 1985).  Reactions that are 
observed in septic conditions can be also seen in other pathological processes that are not 
directly linked to effects of microbes or their products, such as trauma, shock, advanced 
surgical interventions. Therefore the correct definition of sepsis is crucial because different 
approach to understanding sepsis leads to different treatment strategy (primarily, anti-
bacterial) and directly effects the outcome. Biological response to microbial components at 
the beginning of SIRS and sepsis is considered to be immunological reaction of the body in 
order to reduce the number of pathogens.  However unrestricted and excessive production 
of pro- and anti-inflammatory mediators plays the major role in pathogenesis of sepsis and 
MODS. Therefore treatment of sepsis should involve control of mediators of inflammatory 
cascade. Microbial components (such as endotoxin, etc.) and other mediators of 
inflammation (cytokines, chemokines, leukotriens, thromboxanes, platelet activating factor) 
that induce systemic inflammatory syndrome should be eliminated at the early stage of 
sepsis. Some authors proposed restriction of excessive activation of immune system of 
patients with sepsis by inhibiting various elements of inflammatory cascade. Monoclonal 
antibodies against LPS and TNF and other biological regulatory factors were offered to 
achieve the desired effect. However randomized clinical studies did not show clinical 
effectiveness of such agents (Vincent J.-L.&Abraham E., 2006).    Another promising 
approach is the use of selective haemosorption with  LPS-absorbers that allow elimination of 
a large part of bacterial toxins  and inflammatory mediators from patient’s peripheral blood.  
9. Haemosorption with LPS-adsorber for elimination of triggers and 
mediators of inflammation in patients with sepsis and SIRS  
Endotoxin (lipopolysaccharide, LPS) is well known as the main biological substance causing 
Gram-negative septic shock. The lack of clinical success in anti-endotoxin therapies with 
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antibodies determined the development of extracorporeal methods aimed at reducing the 
circulating endotoxin level by adsorption. Theoretically such procedures could prevent 
progression of the systemic inflammatory reaction due to the elimination of inflammation 
trigger factors and mediators (cytokines, bacterial exo- and endotoxins) from the patient’s 
body. The necessity of eliminating a wide spectrum of substances characterized by different 
physical and chemical features from blood stipulates the application of non-selective and 
non-specific methods such as haemosorption. In current clinical practice some devices for 
haemosorption are used as specific (LPS) adsorbers. Launched in 2006 the Alteco® LPS 
Adsorber (Alteco Medical AB, Sweden; class IIa medical device) is based on a tailor-made 
synthetic peptide which is non-toxic and adsorbs endotoxin selectively in a recommended 
single 2-h treatment with a blood flow of 100–200 ml/min and activated clotting time of 
≥180 s (information provided by the manufacturer). 
Data available confirmed an effective reduction in the LPS level in the patients’ blood after 
this procedure (Yaroustovsky M, 2009,  Andersen T.H., 2009). In particular, Kulabukhov VV 
et al. demonstrated almost total elimination of LPS from the patient’s blood (from 1.44 
EU/ml before treatment to 0.03 EU/ml post treatment) (Kulabukhov VV., 2008). This effect 
was accompanied by a reduction in procalcitonin and inflammatory cytokines levels. Also, 
an obvious improvement was observed in the patient’s haemodynamics.  
The same results were shown in the work of T. Ala-Kokko et al.( T. Ala-Kokko, 2009). The 
mean total duration of vasopressor infusion was 46 h shorter in the treatment group 
compared with the control group (95% CI, 104–12 h, p = 0.165), with an average vasopressor 
requirement period of 17.4 ± 6.8 h (95% CI, 5.8–23.8 h) following the start of adsorption 
treatment. The level of LPS decreased in all cases except in one study patient and all were 
without vasopressors at 24 h. The decrease in the Sequential Organ Failure Assessment 
(SOFA) score was 3.4 ± 1.7 from baseline to 24 h after the treatment. The average period of 
hospital stay was 3.4 days shorter in the treatment group (95% CI, 21.7–14.8 days, p = 0.881). 
 
Fig. 6. Inverse correlation of MAP dynamics and vasopressor requirement before and after 
haemosorption by Alteco. 
We studied LPS adsorbers for treating 7 patients with sepsis or septic shock. During the 
course of extracorporeal detoxification a number of clinical parameters were estimated. 
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These were temperature, mean arterial pressure (MAP), central venous pressure (CVP), the 
percentage of available haemoglobin saturated with oxygen (SaO2), the fraction of inspired 
oxygen (FiO2), the partial pressure of oxygen in arterial blood (PaO2), PaO2/FIO2 ratio (an 
index to characterize the acute respiratory distress syndrome), severe hypoxaemia 
(insufficient oxygen content in blood), the biochemical parameters of blood (lactate, 
procalcitonin (PCT)), and concentrations of LPS and cytokines in blood. The requirement for 
vasopressors (Dopamine, Norepinephrine) was also evaluated.  
Data shown in Table 2 and Figure 6 unambiguously demonstrated a pronounced tendency 
towards the oxygen saturation of haemoglobin (SaO2) and normalization of the oxygen 
index (decreasing FiO2 on 22%). This was associated with a rise in MAP and a decrease in 
CVP. Normalization of cardio-vascular system function led to a reduction in the 
requirement for vasopressors.  
 
Parameters Before hemosorption After hemosorption p 
CVP, mm Hg 16±5.0 12±4.1 >0.05 
SaO2 ,% 87±6.1 94±5.9 >0.05 
FiO2 ,% 77±32.3 55±15.4 <0.05* 
PaO2/FiO2 160±70.9 200±54.1 <0.05* 
PCT ng/ml 22±14.3 12±6.0 >0.05 
Lactate, mmol/l 4.3±1.3 4.5±3.2 >0.05 
* Significant difference 
Table 2. Clinical parameters before/after haemosorption by Alteco. 
 
Fig. 7. The body temperature values for patients before and after haemosorption by  
Alteco. 
The significant increase in the respiratory index (ǾaO2/FiO2) after haemosorption 
evidenced the improvement of oxygen diffusion through the alveoli-capillary membrane. 
As a result,  normalization of integral indices, such as body temperature and blood PCT 
level, was observed (Fig.7). 
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The level of LPS, the key trigger signal for system inflammatory reaction, decreased by a 
factor of 2 to 3 versus control after haemosorption (Fig.8). 
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Fig. 8. LPS level in the blood of patients with sepsis before and after haemosorption by 
Alteco. 
As hypercytokinaemia determines the development of SIRS, it seems to be possible that 
reducing cytokine levels (IL-8, IL-1ǃ, IL-6, IL-10 etc) in blood may block the generalization 
of this pathological process or interrupt the cascade of cytokine storm. We studied the 
influence of haemosorption on the cytokine content in blood (Fig. 9).  
Equal portions of sorbent were suspended in equal volumes of physiological solution (0.9% 
NaCl) and put onto the shaker during temperature control. High levels of some cytokines 
(IL-6, IL-8, IL-12, INFǄ and TNF) were indicated in the supernatant (Fig.9).  
We also investigated washouts from a sorbent after the termination of the haemosorption 
procedure. There were no well-developed specific conditions for the extraction and 
quantitative estimation of the characteristics of the sorbent.  
This approach was especially informative in cases in which the level of analyte was higher 
in the blood after haemosorption than before the treatment (see examples in Fig. 9). 
Moreover, an increase in the concentration of some soluble cytokine receptors (sIL-1 II R, 
sIL-6 R) was observed in patient blood after haemosorption (Fig. 10).  
We assumed that this phenomenon was determined by the release of cytokines from their 
complexes with receptors or proteins during the course of haemosorption. 
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       IL-10      IL-8 
   
          IL-1ǃ     IL-6 
Fig. 9. The levels of cytokines in the blood of patients with sepsis before and after 
haemosorption by Alteco. 
 
   
     sIL-1 II R           sIL-6 R 
Fig. 10. Serum levels of soluble receptors in the blood of patients with sepsis before and after 
haemosorption by Alteco. 
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Our results indicated that low levels of serum cytokines revealed by ELISA did not reflect 
the real content of these mediators of inflammation in the blood of patients with septic 
complications. Perhaps a high secretion of cytokines was accompanied by an increase in the 
expression of congruent receptors, which bound a significant quantity of free cytokines in 
ligand-receptor complexes capable of dissociation. We showed that extracorporeal 
detoxification using the Alteco device allowed the elimination not only of free cytokines, but 
also the majority of bound endogenous bioregulators from cytokine/receptor complexes. 
Removal of the trigger factor (LPS) along with a wide range of pro- and anti-inflammatory 
cytokines, and possibly with other inflammation mediators (leukotrienes, thromboxanes, C-
reactive protein) led to the interruption of the systemic inflammatory reaction, which was 
regarded as positive clinical effect of haemosorption for extracorporeal detoxification. 
Correlation analysis demonstrated a close connection between the concentrations in blood of 
LPS and TNFǂ (p= 0.050), LPS and IL-8 (p= 0.050). During the study, a 28-day survival of 9 
critical patients was 96%, only 1 patient died after the procedure.  
Taking into account a high correlation of normalized clinical parameters and the dynamics 
of LPS level and the serum profile of cytokines, the testing parameters (serum levels of IL-
6,TNFǂ, IL-8) could be considered additional indicators of patient’s status during the course 
of treatment, including methods of extracorporeal detoxification. 
We assumed that changes in serum concentrations of cytokines after haemosorption might 
influence the functional activity of immune cells. Neutrophils and natural killers (NK) play 
a crucial role in pathogenesis of organ and multi-organ failures in case of sepsis. Our results 
demonstrated a pronounced tendency towards normalization of the functional activity of 
these innate immunity effectors after haemosorption by Alteco. Thus, phagocytic number 
(PN) and phagocytic index (PI) decreased after haemosorption in 1.3 – 2.1 times and 2.1 – 2.6 
times, respectively. A reduction in spontaneous neutrophil activity was also observed. This 
parameter indicates the intensity of oxygen-dependent phagocytosis associated with the 
release of free radicals destroying the adjacent cells including endothelium. Moreover, the 
decrease was observed in the super-aggressive non-specific reaction of NK: index of 
cytotoxic activity (ICA) reduced after haemosorption from 75-90% to 54-58% (normal for 
healthy volunteers). This effect of normalizing functional activity of neutrophils and NK is 
likely connected with the elimination of LPS molecules and cytokines from peripheral 
blood. 
Stimulation of immune cells for a long period could lead to exhaustion of their killing 
activity, resulting in the circulation of leukocytes that are unable to provide defence 
functions, such as termination of phagocytosis and killing transformed cells. These “ballast” 
cells do not express apoptosis receptor CD95 on their surface membrane, and consequently 
they cannot be eliminated from system circulation.  
It was shown previously that prolongation of life of leukocytes could produce tissue and 
organ damage in case of SIRS and sepsis. A change in apoptosis regulation may influence 
pathogenesis of sepsis and multi-organ failure. We demonstrated the increase in 
ǿD45+CD95+ cell number (from 21-24% to 38-40%) after haemosorption. After the 
treatment, the number of CD45+CD66b+CD95+ neutrophils was higher by 32-42%, which 
correlated with an increase in the number of phagocytes able to terminate oxygen-
dependent phagocytosis. Correlation analysis revealed a strong connection between these 
parameters (Ȟ=0.0086). 
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Therefore, reduction of the functional activity of leukocytes (PN, PI, ICA) to the level of that 
of healthy individuals and simultaneous increase in CD95+ leukocyte level could be 
considered a favourable prognostic factor.  
The obtained results demonstrated that the LPS adsorber could effectively eliminate a wide 
range of the factors from peripheral blood (such as LPS, cytokines, etc.), which mediate all 
the stages of systemic inflammatory reaction in the body. Significant improvement of the 
performance status of patients with sepsis was observed after extracorporeal detoxification 
with LPS adsorber. This was the normalization of cardio-respiratory functions and 
reduction in hyperthermia and vasopressor requirement, normalization of MAP and 
concentration of gases in peripheral blood. 
10. Conclusion 
The discussed data and information show that cancer patients with sepsis have an enhanced 
serum level of LPS as compared to healthy volunteers. There is a close link between a 
decreased serum level of LPB along with the 10-fold reduction of LPB/LPS ratio and poor 
prognosis in cancer patients with sepsis. A characteristic cytokine profile of septic condition 
demonstrated that IL-6, IL-18 and soluble receptor sTNF RI concentrations significantly 
exceeded those of healthy volunteers and therefore high serum concentrations of IL-6, IL-8, 
IL-10, sTNF RI, sIL-1 RII, and sIL-6 R could be suggested as markers of sepsis for cancer 
patients.  
In conclusion, triggers and mediators of inflammation secreted by immune cells play a 
crucial role in pathogenesis of SIRS and sepsis. Management of the inflammatory cascade 
should be considered an essential part of the complex approach to the treatment of systemic 
suppurative septic complications.  
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